Heparin-Induced Thrombocytopenia in Severe COVID-19
- PMID: 32990022
- PMCID: PMC7643786
- DOI: 10.1161/CIRCULATIONAHA.120.049015
Heparin-Induced Thrombocytopenia in Severe COVID-19
Keywords: COVID-19; heparin; thrombocytopenia.
Conflict of interest statement
None.
Comment in
-
Contrast between Prevalence of HIT Antibodies and Confirmed HIT in Hospitalized COVID-19 Patients: A Prospective Study with Clinical Implications.Thromb Haemost. 2021 Jul;121(7):971-975. doi: 10.1055/a-1333-4688. Epub 2021 Jan 27. Thromb Haemost. 2021. PMID: 33296940 No abstract available.
References
-
- Ren B, Yan F, Deng Z, Zhang S, Xiao L, Wu M, Cai L. Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan. Circulation. 2020;142:181–183. doi: 10.1161/CIRCULATIONAHA.120.047407 - PubMed
-
- Warkentin TE. Heparin-induced thrombocytopenia in critically ill patients. Semin Thromb Hemost. 2015;41:49–60. doi: 10.1055/s-0034-1398381 - PubMed
-
- Parzy G, Daviet F, Persico N, Rambaud R, Scemama U, Adda M, Guervilly C, Hraiech S, Chaumoitre K, Roch A, et al. Prevalence and risk factors for thrombotic complications following venovenous extracorporeal membrane oxygenation: a CT scan study. Crit Care Med. 2020;48:192–199. doi: 10.1097/CCM.0000000000004129 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical